Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.55
13.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dimed SA Distribuidora de Medicamentos
Dimed SA Distribuidora de Medicamentos
Cost of Revenue
Dimed SA Distribuidora de Medicamentos
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
Cost of Revenue
-R$3.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Raia Drogasil SA
BOVESPA:RADL3
|
Cost of Revenue
-R$26.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-18%
|
|
|
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
|
Cost of Revenue
-R$7.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
d
|
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
|
Cost of Revenue
-R$1.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Dimed SA Distribuidora de Medicamentos
Glance View
Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
See Also
What is Dimed SA Distribuidora de Medicamentos's Cost of Revenue?
Cost of Revenue
-3.2B
BRL
Based on the financial report for Jun 30, 2024, Dimed SA Distribuidora de Medicamentos's Cost of Revenue amounts to -3.2B BRL.
What is Dimed SA Distribuidora de Medicamentos's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Dimed SA Distribuidora de Medicamentos have been -15% over the past three years , -13% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
